← Back to all trials
Recruiting
NCT06519331
Development of a New Method for Liver Stiffness Measurement Using FibroScan
Conditions: Liver Diseases
Sex: All
Ages: 18 Years – N/A
Healthy volunteers: No
Phase: NA
Enrollment: 153
Sponsor: Echosens
Location: Groupe Hospitalier Nord Essonne - Site Paris- Saclay Orsay
Summary
This is an European, prospective, interventional, multicenter clinical investigation that will take place in 2 French sites. 153 adults patients will be included. The study objective is to develop a new method for measuring liver stiffness using FibroScan.
Eligibility Criteria
Inclusion Criteria:
* Adult patients (≥ 18 years of age) followed in the hepatology or endocrinology department for liver disease, suspected liver disease or consequences of liver disease, all etiologies combined.
* Adult patient able to give his written consent
* Patient affiliated to the French Social Security system
Exclusion Criteria:
* Vulnerable patients
* Patients with liver ascites
* Patients with heart failure
Source: ClinicalTrials.gov (NCT06519331). StuddyBuddy aggregates publicly available trial information.
